AL

Andrew Lurie Salzman

Director Director DIN 00801448
DIN 00801448 First appointment Apr 2005 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Apr 2005
Shareholding value β€’β€’β€’β€’ Premium profile

About Andrew Lurie Salzman

Data last updated:

Andrew Lurie Salzman has 21 years in corporate governance. Formerly with 1 company, such as India Inotek Clinical Research Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00801448
Primary Designation Director
First Appointment 25 Apr 2005
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Apr 20052005–Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
India Inotek Clinical Research Private Limited
Premium access

Shareholding and investment profile for Andrew Lurie Salzman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Andrew Lurie Salzman

Andrew Lurie Salzman has 21 years in corporate governance. Formerly with 1 company, such as India Inotek Clinical Research Private Limited. Engaged in General Business. Contributes to corporate operations.

Andrew Lurie Salzman has expertise in General Business.

Andrew Lurie Salzman has 21 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available